rs2294995
Positions:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_001853.4(COL9A3):āc.1740T>Cā(p.Pro580=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.69 in 1,611,778 control chromosomes in the GnomAD database, including 387,113 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.75 ( 43619 hom., cov: 32)
Exomes š: 0.68 ( 343494 hom. )
Consequence
COL9A3
NM_001853.4 synonymous
NM_001853.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.940
Genes affected
COL9A3 (HGNC:2219): (collagen type IX alpha 3 chain) This gene encodes one of the three alpha chains of type IX collagen, the major collagen component of hyaline cartilage. Type IX collagen, a heterotrimeric molecule, is usually found in tissues containing type II collagen, a fibrillar collagen. Mutations in this gene are associated with multiple epiphyseal dysplasia type 3. [provided by RefSeq, Jan 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.75).
BP6
Variant 20-62837219-T-C is Benign according to our data. Variant chr20-62837219-T-C is described in ClinVar as [Benign]. Clinvar id is 258417.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr20-62837219-T-C is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-0.94 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.921 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
COL9A3 | NM_001853.4 | c.1740T>C | p.Pro580= | synonymous_variant | 30/32 | ENST00000649368.1 | NP_001844.3 | |
COL9A3 | XM_047439893.1 | c.1917T>C | p.Pro639= | synonymous_variant | 29/31 | XP_047295849.1 | ||
COL9A3 | XM_047439894.1 | c.1179T>C | p.Pro393= | synonymous_variant | 30/32 | XP_047295850.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
COL9A3 | ENST00000649368.1 | c.1740T>C | p.Pro580= | synonymous_variant | 30/32 | NM_001853.4 | ENSP00000496793 | P1 |
Frequencies
GnomAD3 genomes AF: 0.748 AC: 113705AN: 151936Hom.: 43553 Cov.: 32
GnomAD3 genomes
AF:
AC:
113705
AN:
151936
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.681 AC: 168289AN: 247034Hom.: 58133 AF XY: 0.674 AC XY: 90668AN XY: 134500
GnomAD3 exomes
AF:
AC:
168289
AN:
247034
Hom.:
AF XY:
AC XY:
90668
AN XY:
134500
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.684 AC: 998414AN: 1459724Hom.: 343494 Cov.: 66 AF XY: 0.681 AC XY: 494259AN XY: 726294
GnomAD4 exome
AF:
AC:
998414
AN:
1459724
Hom.:
Cov.:
66
AF XY:
AC XY:
494259
AN XY:
726294
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.749 AC: 113837AN: 152054Hom.: 43619 Cov.: 32 AF XY: 0.742 AC XY: 55166AN XY: 74326
GnomAD4 genome
AF:
AC:
113837
AN:
152054
Hom.:
Cov.:
32
AF XY:
AC XY:
55166
AN XY:
74326
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2266
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:5
Benign, no assertion criteria provided | clinical testing | Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ | - | - - |
Benign, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, Amsterdam University Medical Center | - | - - |
Benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Benign, no assertion criteria provided | clinical testing | Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen | - | - - |
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 03, 2015 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Epiphyseal dysplasia, multiple, 3 Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 30, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at